1. Merck trashes both of its COVID vaccine candidates due to weak clinical data — Big medtech deals keep on turning — Moderna says its COVID-19 vaccine is less effective against the South African variant — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Medimmune IT


Sort By:
Title
Replies Views
Last Message
  1. Anonymous
    Replies:
    5
    Views:
    17,198

Thread Display Options

Loading...